venerdì, 31 marzo 2023

Notizie AIOM – anno XV n. 645

FDA conducts major global operation to protect consumers from potentially dangerous prescription drugs sold online

September 25, 2017 - The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, recently took action against more than 500 websites that illegally sell potentially dangerous, unapproved versions of prescription medicines, ...
Leggi tutto

28 settembre 2017 – FDA approva un nuovo trattamento per gli adulti con linfoma follicolare recidivato

28 settembre 2017 – Comunicazione relativa a Pay-Back 5%

28 settembre 2017 – Chiusura Registro di monitoraggio Eribulina

29 settembre 2017 – Nota Informativa Importante su Epoetina

29 settembre 2017 – AIFA. Pubblicazione schede di monitoraggio Registro Tolvaptan

29 settembre 2017 – Comunicazione EMA su paracetamolo a rilascio modificato

Second Annual ASCO Advocacy Summit Convenes in Washington, DC

September 28, 2017 - Nearly 100 oncology care providers from across the United States traveled to Capitol Hill on September 27 and 28 to participate in the second annual ASCO Advocacy Summit. Advocates met with Members of Congress and their staff to educate them on critical ...
Leggi tutto

FDA Approves Abemaciclib for HR+/HER2- Breast Cancer

September 28, 2017 - The FDA approved abemaciclib for use in combination with fulvestrant in women with HR+/HER2- advanced breast cancer with disease progression following endocrine therapy. The CDK4/6 inhibitor has also been approved as a monotherapy for patients with HR+/HER2- ...
Leggi tutto

FDA improves access to reports of adverse drug reactions

September 28, 2017 - The U.S. Food and Drug Administration today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA’s Adverse Event Reporting System (FAERS). The tool is ...
Leggi tutto